|
1
|
Lee M, Saver JL, Chang B, Chang KH, Hao Q
and Ovbiagele B: Presence of baseline prehypertension and risk of
incident stroke: A meta-analysis. Neurology. 77:1330–1337. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sipahi I, Swaminathan A, Natesan V,
Debanne SM, Simon DI and Fang JC: Effect of antihypertensive
therapy on incident stroke in cohorts with prehypertensive blood
pressure levels: A meta-analysis of randomized controlled trials.
Stroke. 43:432–440. 2012. View Article : Google Scholar
|
|
3
|
Takemori K, Ishida H and Ito H: Continuous
inhibition of the renin-angiotensin system and protection from
hypertensive end-organ damage by brief treatment with angiotensin
II type 1 receptor blocker in stroke-prone spontaneously
hypertensive rats. Life Sci. 77:2233–2245. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hamaguchi R, Takemori K, Inoue T, Masuno K
and Itox H: Short-term treatment of stroke-prone spontaneously
hypertensive rats with an AT1 receptor blocker protects against
hypertensive end-organ damage by prolonged inhibition of the
renin-angiotensin system. Clin Exp Pharmacol Physiol. 35:1151–1155.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dahlöf B, Devereux RB, Kjeldsen SE, Julius
S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K,
Lederballe-Pedersen O, et al LIFE Study Group: Cardiovascular
morbidity and mortality in the Losartan Intervention For Endpoint
reduction in hypertension study (LIFE): A randomised trial against
atenolol. Lancet. 359:995–1003. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McLachlan J, Beattie E, Murphy MP, Koh-Tan
CH, Olson E, Beattie W, Dominiczak AF, Nicklin SA and Graham D:
Combined therapeutic benefit of mitochondria-targeted antioxidant,
MitoQ10, and angiotensin receptor blocker, losartan, on
cardiovascular function. J Hypertens. 32:555–564. 2014. View Article : Google Scholar :
|
|
7
|
Judd E and Jaimes EA: Aliskiren,
amlodipine and hydrochlorothiazide triple combination for
hypertension. Expert Rev Cardiovasc Ther. 10:293–303. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Messerli FH and Staessen JA: Amlodipine
better than lisinopril? How one randomized clinical trial ended
fallacies from observational studies. Hypertension. 48:359–361.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang JG, Li Y, Franklin SS and Safar M:
Prevention of stroke and myocardial infarction by amlodipine and
Angiotensin receptor blockers: A quantitative overview.
Hypertension. 50:181–188. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He DH, Zhang LM, Lin LM, Ning RB, Wang HJ,
Xu CS and Lin JX: Long-term prehypertension treatment with losartan
effectively prevents brain damage and stroke in stroke-prone
spontaneously hypertensive rats. Int J Mol Med. 33:301–309.
2014.
|
|
11
|
Julius S, Kjeldsen SE, Weber M, Brunner
HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, et
al VALUE trial group: Outcomes in hypertensive patients at high
cardiovascular risk treated with regimens based on valsartan or
amlodipine: The VALUE randomised trial. Lancet. 363:2022–2031.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ogihara T, Nakao K, Fukui T, Fukiyama K,
Ueshima K, Oba K, Sato T and Saruta T; Candesartan Antihypertensive
Survival Evaluation in Japan Trial Group: Effects of candesartan
compared with amlodipine in hypertensive patients with high
cardiovascular risks: Candesartan antihypertensive survival
evaluation in Japan trial. Hypertension. 51:393–398. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamori Y, Horie R, Akiguchi I, Kihara M,
Nara Y and Lovenberg W: Symptomatological classification in the
development of stroke in stroke-prone spontaneously hypertensive
rats. Jpn Circ J. 46:274–283. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Higuchi S, Ohtsu H, Suzuki H, Shirai H,
Frank GD and Eguchi S: Angiotensin II signal transduction through
the AT1 receptor: Novel insights into mechanisms and
pathophysiology. Clin Sci (Lond). 112:417–428. 2007. View Article : Google Scholar
|
|
15
|
Lin JX and Lin LM: Prehypertensive
treatment in spontaneously hypertensive rats: A comparison of
losartan and amlodipine regarding blood pressure control and
cardiovascular protection after drug withdrawal. Int J Cardiol.
137:S1322009. View Article : Google Scholar
|
|
16
|
Morton JJ, Beattie EC and MacPherson F:
Angiotensin II receptor antagonist losartan has persistent effects
on blood pressure in the young spontaneously hypertensive rat: Lack
of relation to vascular structure. J Vasc Res. 29:264–269. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Harrap SB, Van der Merwe WM, Griffin SA,
Macpherson F and Lever AF: Brief angiotensin converting enzyme
inhibitor treatment in young spontaneously hypertensive rats
reduces blood pressure long-term. Hypertension. 16:603–614. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ishiguro K, Sasamura H, Sakamaki Y, Itoh H
and Saruta T: Developmental activity of the renin-angiotensin
system during the “critical period” modulates later L-NAME-induced
hypertension and renal injury. Hypertens Res. 30:63–75. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sasamura H, Hayashi K, Ishiguro K, Nakaya
H, Saruta T and Itoh H: Prevention and regression of hypertension:
Role of renal microvascular protection. Hypertens Res. 32:658–664.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bergström G, Johansson I, Wickman A, Gan L
and Thorup C: Brief losartan treatment in young spontaneously
hypertensive rats abates long-term blood pressure elevation by
effects on renal vascular structure. J Hypertens. 20:1413–1421.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Edvinsson L: Cerebrovascular angiotensin
AT1 receptor regulation in cerebral ischemia. Trends Cardiovasc
Med. 18:98–103. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kasahara Y, Taguchi A, Uno H, Nakano A,
Nakagomi T, Hirose H, Stern DM and Matsuyama T: Telmisartan
suppresses cerebral injury in a murine model of transient focal
ischemia. Brain Res. 1340:70–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Iwai M, Liu HW, Chen R, Ide A, Okamoto S,
Hata R, Sakanaka M, Shiuchi T and Horiuchi M: Possible inhibition
of focal cerebral ischemia by angiotensin II type 2 receptor
stimulation. Circulation. 110:843–848. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McCarthy CA, Vinh A, Callaway JK and
Widdop RE: Angiotensin AT2 receptor stimulation causes
neuroprotection in a conscious rat model of stroke. Stroke.
40:1482–1489. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Denker MG and Cohen DL: What is an
appropriate blood pressure goal for the elderly: Review of recent
studies and practical recommendations. Clin Interv Aging.
8:1505–1517. 2013.PubMed/NCBI
|
|
26
|
Umemoto S, Ogihara T, Rakugi H, Matsumoto
M, Kitagawa K, Shimada K, Higaki J, Ito S, Suzuki H, Ohashi Y, et
al Combination Therapy of Hypertension to Prevent Cardiovascular:
Effects of a benidipine-based combination therapy on the risk of
stroke according to stroke subtype: The COPE trial. Hypertens Res.
36:1088–1095. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Aronow WS: Hypertension-related stroke
prevention in the elderly. Curr Hypertens Rep. 15:582–589. 2013.
View Article : Google Scholar : PubMed/NCBI
|
